SEC Form 4/A · accession 0001179110-17-013158
IDERA PHARMACEUTICALS, INC. · IDRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Youssef El Zein
Director · 10% Owner
Period of report
Oct 2, 2017
Accepted (ET)
Oct 5, 2017 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000861838
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 2, 2017 | A | 4,721 | $2.28 | A | 539,410 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This amendment is being filed to correct the amount of securities beneficially owned by the Reporting Person following the Reported Transaction.
Remarks
A Power of Attorney is on file for this Reporting Person.